Neurophysiological aspects of centrally acting peptides.
D000818:Animals; D001001:Anura / Q000502:physiology; D001921:Brain / Q000187:drug effects; D005071:Evoked Potentials; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology*; D007031:Hypothalamus / Q000502:physiology*; D007478:Iontophoresis; D009419:Nerve Tissue Proteins / Q000494:pharmacology / Q000502:physiology*; D009434:Neural Pathways / Q000502:physiology; D009479:Neuropeptides / Q000502:physiology*; D018377:Neurotransmitter Agents; D010904:Pituitary Gland, Posterior / Q000378:metabolism / Q000502:physiology; D010906:Pituitary Hormone-Releasing Hormones / Q000378:metabolism; D051381:Rats; D009435:Synaptic Transmission / Q000187:drug effects; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology / Q000502:physiology
D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D010906:Pituitary Hormone-Releasing Hormones; D013973:Thyrotropin-Releasing Hormone